Becton, Dickinson (BDX) Beats on Q4 Earnings and Revenues
Becton, Dickinson and Company BDX, also known as BD, reported fourth-quarter fiscal 2019 earnings per share (EPS) of $3.31, which beat the Zacks Consensus Estimate by a penny. The bottom line also improved 13% on a year-over-year basis and rose 12.3% at constant currency (cc).FY19 at a Glance BD Medical BD Life Sciences BD Interventional
Becton, Dickinson and Company Price, Consensus and EPS Surprise
EW TMO RMD the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here More Stock News: This Is Bigger than the iPhone!
Click to get this free report
Thermo Fisher Scientific Inc. (TMO): Free Stock Analysis Report
Edwards Lifesciences Corporation (EW): Free Stock Analysis Report
ResMed Inc. (RMD): Free Stock Analysis Report
Becton, Dickinson and Company (BDX): Free Stock Analysis Report
To read this article on Zacks.com click here.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.